Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage i uterine sarcomas. A pilot study
- 15 April 1986
- Vol. 57 (8) , 1451-1454
- https://doi.org/10.1002/1097-0142(19860415)57:8<1451::aid-cncr2820570802>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Autopsy findings in patients with uterine sarcomaGynecologic Oncology, 1984
- Uterine sarcomas: A clinicopathologic study, 1965–1981Gynecologic Oncology, 1984
- Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamideGynecologic Oncology, 1983
- Metastatic sarcomas: Chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristineCancer, 1981
- Prophylactic chemotherapy in stages I and II uterine sarcomaGynecologic Oncology, 1979
- Complete remission of widely metastatic endometrial stromal sarcoma following combination chemotherapyCancer, 1979
- Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximideAmerican Journal of Obstetrics and Gynecology, 1979
- Cyclophosphamide in solid tumorsCancer Treatment Reviews, 1975
- UTERINE SARCOMAS: HISTOGENESIS AND TAXONOMYAnnals of the New York Academy of Sciences, 1959